Cleared Traditional

SONOSITE NANOMAXX SERIES ULTRASOUND SYSTEM (K092058) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2009
Decision
86d
Days
Class 2
Risk

K092058 is an FDA 510(k) clearance for the SONOSITE NANOMAXX SERIES ULTRASOUND SYSTEM. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.

Submitted by Sonosite,Inc. (Bothell, US). The FDA issued a Cleared decision on October 2, 2009 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sonosite,Inc. devices

Submission Details

510(k) Number K092058 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 08, 2009
Decision Date October 02, 2009
Days to Decision 86 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 107d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code IYN System, Imaging, Pulsed Doppler, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYN System, Imaging, Pulsed Doppler, Ultrasonic

All 535
Devices cleared under the same product code (IYN) and FDA review panel - the closest regulatory comparables to K092058.
ACUSON
K111674 · Siemens Medical Solutions USA, Inc. · Jun 2011
SC2000 DIAGNOSTIC ULTRASOUND SYSTEM
K102017 · Siemens Medical Solutions USA, Inc. · Sep 2010
ACUSON S2000 DIAGNOSTIC ULTRASOUND SYSTEM
K093812 · Siemens Medical Solutions USA, Inc. · Mar 2010
ACUSON P50 ULTRASOUND SYSTEM
K083114 · Siemens Medical Solutions USA, Inc. · Mar 2009
GE VIVID E9 ULTRASOUND
K081921 · General Electric Co. · Aug 2008
GE LOGIQ P6
K073297 · General Electric Co. · Dec 2007